Clinical Trial Update: Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

This clinical trial update outlines a Phase 4 study evaluating the efficacy and safety of a combination of Henagliflozin Proline, Retagliptin, and Metformin in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin Proline (henagliflozin proline)
• Retagliptin (Retagliptin)
• metformin (metformin)

Snippet

Sponsor: Peking University First Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING